Company Description
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments.
It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions.
Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions.
The company has strategic partnership agreements with TriHealth, Northwell, Atrium Health, Mayo Clinic, and Edith Cowan University.
The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013.
Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
| Country | Netherlands |
| Founded | 1891 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 69,656 |
| CEO | Roy Jakobs |
Contact Details
Address: Philips Center, Amstelplein 2 Amsterdam, 1096 BC Netherlands | |
| Phone | 31 20 597 7777 |
| Website | philips.com |
Stock Details
| Ticker Symbol | PHG |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| CIK Code | 0000313216 |
| CUSIP Number | 500472303 |
| ISIN Number | US5004723038 |
| SIC Code | 3844 |
Key Executives
| Name | Position |
|---|---|
| Roy Jakobs | Chief Executive Officer |
| Charlotte Hanneman | Chief Financial Officer |
| Willem Appelo | Chief Operating Officer |
| Leandro Mazzoni | Head of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 28, 2024 | 6-K | Report of foreign issuer |
| Sep 3, 2024 | 6-K | Report of foreign issuer |
| Aug 30, 2024 | 6-K | Report of foreign issuer |
| Aug 23, 2024 | 6-K | Report of foreign issuer |
| Aug 5, 2024 | 6-K | Report of foreign issuer |
| Jul 29, 2024 | 6-K | Report of foreign issuer |
| Jun 25, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Jun 20, 2024 | 6-K | Report of foreign issuer |
| May 28, 2024 | SD | Form - SD |
| May 24, 2024 | 6-K | Report of foreign issuer |